Eiger BioPharmaceuticals, Inc.
COMPOSITIONS OF EXENDIN-4 DERIVATIVES
Last updated:
Abstract:
In one aspect, exendin-4 derivative compositions are provided. In some embodiments, unit dose forms and kits containing such compositions are also provided. In some embodiments, such compositions are useful for treatment of hyperinsulinemic hypoglycemia.
Status:
Application
Type:
Utility
Filling date:
10 Aug 2021
Issue date:
2 Dec 2021